Insightsclaudio.dangelo@spexcapital.com2022-03-24T14:38:28+00:00

Insights

Insights

Spex Capital – One Year in Review

MushM2022-05-06T10:23:27+01:00May 6, 2022|Corporate|

Log my Care – Our Journey to Success

MushM2022-03-29T14:16:45+01:00March 29, 2022|Profile|

Mobihealth News: What’s next for digital health in 2022?

MushM2022-01-04T10:27:21+00:00December 29, 2021|News|

Doctor vs Machine: The Future of Medical Diagnostics

MushM2021-10-22T10:44:19+01:00October 21, 2021|Report|

Mobihealth News: Spex Capital & Medcity joint investment call

MushM2021-10-22T10:45:58+01:00September 24, 2021|News|

Yahoo Finance: Spex Capital and MedCity joint investment call goes live to source and fund breakthrough health-tech ventures

MushM2021-10-14T17:02:28+01:00September 15, 2021|News|

TechRound: Claudio D’Angelo, MD at Spex Capital: The Impact of COVID-19 on HealthTech And Strategic Guidance For Health Tech Start Ups

MushM2021-10-14T17:02:37+01:00August 18, 2021|News|

Spex Capital and MedCity partner to drive investment in promising health tech ventures

MushM2021-08-15T23:02:40+01:00August 5, 2021|News|

MEDCITY Q&A: Claudio D’Angelo – Spex Capital

MushM2021-10-14T17:02:49+01:00July 29, 2021|Profile|

Laing Buisson News: Spex Capital joins forces with MedCity to fund early stage health tech

MushM2021-10-14T17:02:57+01:00July 22, 2021|News|

Spex Capital – One Year in Review

MushM2022-05-06T10:23:27+01:00May 6, 2022|Corporate|

Log my Care – Our Journey to Success

MushM2022-03-29T14:16:45+01:00March 29, 2022|Profile|

Mobihealth News: What’s next for digital health in 2022?

MushM2022-01-04T10:27:21+00:00December 29, 2021|News|